ALB and Alzheimer disease: The initial rationale behind the PE‐Alb‐based strategy was that routine removal of AD patient's plasma and, consequently, elimination of peripheral amyloid‐beta peptide (Aβ) species would favor the efflux of Aβ from brain to plasma,6 where Aβ circulates bound to albumin.7, 8